MacroGenics(美國(guó))

MacroGenics

美國(guó)MacroGenicswww.macrogenics.com MACROGENICS是美國(guó)的生物技術(shù)制藥公司，擁有癌癥以及炎癥性疾病的抗體治療多個(gè)技術(shù)平臺(tái),其中4個(gè)創(chuàng)新藥物已經(jīng)進(jìn)入臨床研究，并已與美國(guó)的輝瑞（Pfizer），德國(guó)的勃林格殷格翰（Boehringer-Ingelheim）等國(guó)際企業(yè)建立了長(zhǎng)期合作的關(guān)系。Sinceitsfoundingin2000,MacroGenicshasfo cusedonapplyingitsworld-classantibodycapabilitiestodiscover,developanddelivertopatientsnovelbiologicsforthetreatmentofcancer,autoimmunedisordersandinfectiousdiseases.Ourteamof135dedicatedindividualsiscommittedtoapplybreakthroughsciencetocreatelife-changingmedicines.Asanexample,ourleadautoimmuneproductcandidate,teplizumab,isthoughttoreprogramtheimmunesystemtore-establishthelostimmunebalancethatoccursinautoimmunediseasessuchastype1diabetes.Ifsuccessful,thisapproachwouldrepresentaparadigmshiftinthemanagementofadiseaseforwhichtherehasbeennonewtreatmentsincetheintroductionofinsulininthe1920’s.Ourinnovativeproductcandidatesl